1. Scrip
  2. >>Business

Bluebird Spins Off Oncology Business As Cell, Gene Therapy Segments Grow Apart

Gene Therapy Focus Opens Partnering, Acquisition Opportunities

 
• By Alaric DeArment

Nick Leschly will become CEO of oncology-focused spinoff, while Andrew Obenshain will help gene therapy-focused bluebird

Cancer
Bluebird will spin off its oncology business into a new company. • Source: Shutterstock

As its cell and gene therapy segments have gradually grown apart, bluebird bio has decided they will work better as separate companies, which may streamline the path to market for its oncology products while creating partnering or even acquisition opportunities for its gene therapies business. The firm announced the split, which is expected to be complete by the end of 2021, on 11 January, the opening day of the J.P. Morgan conference.

Both companies will operate independently and trade publicly

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Finance Watch: Deerfield Closes $600m-Plus VC Fund; Gates Speeds Up Health Investments

 
• By Mandy Jackson

Private Company Edition: Deerfield’s third innovations fund will back therapeutics and other opportunities, the Gates Foundation – a sometimes funder of biotech firms – will spend $200bn over the next 20 years, and NewLimit raised a $130m series B round, among other financings.

Pipeline Watch: Six Approvals And Thirteen Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pharma Left Hanging After US/UK Trade Pact

 
• By Kevin Grogan

An ‘historic economic prosperity deal’ does not include the sector.